The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post‐first and post‐second hematopoietic stem cell transplant
Authors:
- 23 March 2015
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 19 (4) , 391-398
Abstract
The reported incidence of post‐allogeneic HSCT AIHA was between 4.4% and 6% following a single transplant. Cord blood transplantation, T‐cell depletion, and chronic GvHD are significantly associated with post‐transplant AIHA. During an 11‐yr period, data for 500 pediatric HSCT recipients were eligible for evaluation of the incidence of AIHA post‐first and post‐second transplants. Demographic, transplant, and post‐transplant‐related variables were analyzed. Twelve of 500 (2.4%) recipients at a median of 273 days and seven of 72 (9.7%) recipients at a median of 157 days developed AIHA post‐first and post‐second HSCT, respectively. Post‐first HSCT, none of the MRD recipients developed AIHA (0/175 MRD vs. 12/325 other donors, p = 0.04). Four of 12 required a second HSCT to control the AIHA. After the second HSCT, MUD was significantly associated with the development of AIHA. No other variables were associated with the post‐second transplant AIHA. The incidence of AIHA post‐first and post‐second HSCT was less than the reported. The increased incidence of AIHA among recipients of second HSCT is most likely due to the profound immune dysregulation. A much larger, prospective study would be needed to evaluate the incidence, complications, and management of post‐transplant AIHA.Keywords
Funding Information
- National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health ,The University of New Mexico Clinical and Translational Science Center (8UL1TR000041)
This publication has 28 references indexed in Scilit:
- Allogeneic hematopoietic SCT for patients with autoimmune diseasesBone Marrow Transplantation, 2009
- Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath‐1HPediatric Blood & Cancer, 2007
- Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioningBone Marrow Transplantation, 2006
- T-cell-depleted stem cell boost for the treatment of autoimmune haemolytic anaemia after T-cell-depleted allogeneic bone marrow transplantation complicated by adenovirus infectionBone Marrow Transplantation, 2006
- Unrelated Umbilical Cord Blood Transplantation for an Infant With ??-Thalassemia MajorJournal of Pediatric Hematology/Oncology, 2004
- Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusionsBone Marrow Transplantation, 2001
- Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host diseaseBone Marrow Transplantation, 2001
- Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantationBone Marrow Transplantation, 1999
- De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplantBone Marrow Transplantation, 1997
- Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplantBone Marrow Transplantation, 1997